It seems we can’t find what you’re looking for. Perhaps searching can help.
Nothing found
-
Tetra Bio-Pharma (OTC: TBPMF), (TSX: TBP) has a robust clinical pipeline that targets markets valued at more than of $250B combinedTBPMF should be trading at $2.00+ right now based on typical valuations of companies in [...] -
-
-
-
-
Analyst Notes NexTech AR Solutions (OTC: NEXCF) (CSE: NTAR) REVISED Upside Potential Target: US$20.00 (next 12 months.) Current Stock Price: US$2.00 (January 28, 2020) (Initial Discovery Report published: November 6, 2019 ($1.06) $5.00 upside target) [...] -
-
-
-